Based on this YouTube video's total view count of 807K views and industry-standard rates, the estimated total earning is $565 - $1.61K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Ivermectin and COVID 19 with 807,188 views, 16,468 likes, and 6,248 comments. Experience the impact of this video content that has captured audience attention.

Ivermectin https://bnf.nice.org.uk/drug/ivermectin.html#indicationsAndDoses Invitro antiviral activity Against a broad range of viruses HIV, dengue, influenza, Zika virus Invitro antiviral, SARS-CoV-2 activity 99.8% reduction in viral RNA after 48 h Worldwide use for treating COVID-19 About 3.7 billion doses of ivermectin have been distributed globally over the past 30 years EVMS CRITICAL CARE COVID-19 MANAGEMENT PROTOCOL https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf Preexposure prophylaxis in high-risk patients Postexposure prophylaxis Symptomatic patients at home Mildly symptomatic patients in hospital Progressive Respiratory symptoms Ivermectin has emerged as the “wonder drug” to prophylaxis and treat COVID-19 Ivermectin inhibits viral replication and has potent anti-inflammatory properties There is the potential for serious drug-drug interaction Additional, studies are urgently required to confirm these very impressive preliminary findings Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 (7th December) https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf Front Line COVID-19 Critical Care Alliance (FLCCC) One Sentence Summary Review of recently available clinical trial results demonstrating efficacy of ivermectin in prophylaxis and treatment of COVID-19. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 The ICON Study (October 2020, South Florida) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550891/ Research Question Does ivermectin benefit hospitalized coronavirus disease 2019 (COVID-19) patients? Study Design and Methods Consecutive patients hospitalized Four hospitals in Florida Confirmed COVID-19 March 15 and May 11, 2020 Treated with or without ivermectin Primary outcome All-cause in-hospital mortality Secondary outcomes, mortality in patients with severe pulmonary involvement, extubation rates for mechanically ventilated patients, length of stay Severe pulmonary involvement Need for Fio2 ≥ 50%, noninvasive ventilation Invasive ventilation Results from reviews N = 280 Ivermectin treated = 173 Overall mortality 15% Mortality with severe pulmonary involvement = 38.8% Not given ivermectin = 107 Overall mortality 25% (OR, 0.52) Mortality with severe pulmonary involvement = 80.7% No significant differences were found in extubation rates or length of stay Most patients in both groups also received hydroxychloroquine, azithromycin, or both Interpretation Ivermectin treatment was associated with lower mortality during treatment of COVID-19 Especially in patients with severe pulmonary involvement Randomized controlled trials are needed to confirm these findings Ivermectin news https://www.newswise.com/coronavirus/flccc-alliance-calls-on-national-health-authorities-to-immediately-review-medical-evidence-showing-the-efficacy-of-ivermectin-for-the-prevention-of-covid-19-and-as-an-early-outpatient-treatment

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.